{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:21:31Z","timestamp":1781097691208,"version":"3.54.1"},"reference-count":82,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016133","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:52:20Z","timestamp":1742298740000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Statins for preventing preeclampsia"],"prefix":"10.1002","volume":"2025","author":[{"given":"Themistoklis","family":"Paraskevas","sequence":"additional","affiliation":[{"name":"Department of Nephrology; General University Hospital of Patras; Patras Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Gakis","sequence":"additional","affiliation":[{"name":"General University Hospital of Patras; University of Patras; Patras Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Papapanou","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology; Aretaieion University Hospital, National and Kapodistrian University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros N","family":"Sergentanis","sequence":"additional","affiliation":[{"name":"Department of Public Health Policy; School of Public Health, University of West Attica; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Sotiriadis","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynaecology; Faculty of Medicine, Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos S","family":"Siristatidis","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Unit, Second Department of Obstetrics and Gynaecology; Medical School, National and Kapodistrian University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD016133-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/jcm8101625","article-title":"Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring","volume":"8","author":"Fox","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD016133-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222 Obstetrics & Gynecology 2020 135 6 e237 60 10.1097\/AOG.0000000000003891","DOI":"10.1097\/AOG.0000000000003891"},{"issue":"5","key":"10.1002\/14651858.CD016133-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nature Reviews Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD016133-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e31143","DOI":"10.7759\/cureus.31143","article-title":"Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"issue":"14","key":"10.1002\/14651858.CD016133-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia\u2014pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/15513815.2023.2274823","article-title":"Human placenta and evolving insights into pathological changes of preeclampsia: a comprehensive review of the last decade","volume":"43","author":"Chiorean","year":"2023","journal-title":"Fetal and Pediatric Pathology"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD016133-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1161\/HYPERTENSIONAHA.122.18996","article-title":"Increased risk of preeclampsia in women with a genetic predisposition to elevated blood pressure","volume":"79","author":"Kivioja","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/bmjnph-2021-000399","article-title":"Dietary factors that affect the risk of pre-eclampsia","volume":"5","author":"Perry","year":"2022","journal-title":"BMJ Nutrition, Prevention and Health"},{"issue":"11","key":"10.1002\/14651858.CD016133-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/biom11111625","article-title":"Long-term consequences of placental vascular pathology on the maternal and offspring cardiovascular systems","volume":"11","author":"Benagiano","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1002\/14651858.CD016133-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD016133-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circulation Research"},{"issue":"4","key":"10.1002\/14651858.CD016133-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajog.2022.04.034","article-title":"Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis","volume":"227","author":"Beardmore-Gray","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2018","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/uog.26222","article-title":"ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy","volume":"61","author":"Rolnik","year":"2023","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD016133-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1373\/clinchem.2018.289801","article-title":"Updates on screening, prevention, treatment, and genetic markers for preeclampsia","volume":"64","author":"Palomaki","year":"2018","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin toxicity","volume":"124","author":"Ward","year":"2019","journal-title":"Circulation Research"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.cir.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"issue":"25, Part B","key":"10.1002\/14651858.CD016133-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1074248407300380","article-title":"Do statins lower blood pressure?","volume":"12","author":"Mangat","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"25","key":"10.1002\/14651858.CD016133-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000624","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.6515\/acs20160611a","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar","year":"2016","journal-title":"Acta Cardiologica Sinica"},{"issue":"21","key":"10.1002\/14651858.CD016133-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD016133-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1172\/JCI89137","article-title":"Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome","volume":"126","author":"Costantine","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1002\/14651858.CD016133-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013673.pub2","article-title":"Pravastatin for lowering lipids","author":"Adams","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"101260","DOI":"10.1016\/j.ajogmf.2023.101260","article-title":"The role of pravastatin in preventing preeclampsia in high-risk pregnant women: a meta-analysis with trial sequential analysis","volume":"6","author":"Provinciatto","year":"2024","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ogc.2022.10.005","article-title":"Aspirin and pravastatin for preeclampsia prevention in high-risk pregnancy","volume":"50","author":"Eid","year":"2023","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD016133-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"106824","DOI":"10.1016\/j.vph.2020.106824","article-title":"Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction","volume":"137","author":"Jurisic","year":"2021","journal-title":"Vascular Pharmacology"},{"issue":"25","key":"10.1002\/14651858.CD016133-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1080\/14767058.2021.1940940","article-title":"Pravastatin is useful for prevention of recurrent severe placenta-mediated complications\u2014a pilot study","volume":"35","author":"Kupferminc","year":"2022","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD016133-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"14","key":"10.1002\/14651858.CD016133-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1055\/s-0040-1713651","article-title":"Evaluating the effect of pravastatin in early-onset fetal growth restriction: a nonrandomized and historically controlled pilot study","volume":"38","author":"Mendoza","year":"2021","journal-title":"American Journal of Perinatology"},{"issue":"4","key":"10.1002\/14651858.CD016133-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/antiox12040939","article-title":"Pravastatin prevents increases in activity of metalloproteinase-2 and oxidative stress, and enhances endothelium-derived nitric oxide-dependent vasodilation in gestational hypertension","volume":"12","author":"Toghi","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1002\/14651858.CD016133-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG"},{"issue":"3","key":"10.1002\/14651858.CD016133-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/a-1673-5603","article-title":"INOVASIA study: a randomized open controlled trial to evaluate pravastatin to prevent preeclampsia and its effects on sFlt1\/PlGF levels","volume":"41","author":"Akbar","year":"2021","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD016133-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.preghy.2020.11.014","article-title":"Effects of statins on preeclampsia: A systematic review","volume":"23","author":"Vahedian-Azimi","year":"2021","journal-title":"Pregnancy Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD016133-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD016133-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-023-00869-z","article-title":"Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course","volume":"20","author":"Gaillard","year":"2023","journal-title":"Nature Reviews Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD016133-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"e2141321","DOI":"10.1001\/jamanetworkopen.2021.41321","article-title":"Perinatal outcomes after statin exposure during pregnancy","volume":"4","author":"Chang","year":"2021","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1002\/14651858.CD016133-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14740338.2023.2251888","article-title":"Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)","volume":"23","author":"Wu","year":"2024","journal-title":"Expert Opinion on Drug Safety"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1701-2163(15)30565-X","article-title":"The fetal safety of statins: a systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"Journal d'Obstetrique et Gynecologie du Canada"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD016133-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCULATIONAHA.121.058983","article-title":"Statin use in pregnancy: is it time for a paradigm shift?","volume":"145","author":"Mauricio","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0045|cit45","first-page":"39","article-title":"FDA approval for use of medications in pregnancy: an uphill battle","volume":"4","author":"Norwitz","year":"2011","journal-title":"Reviews in Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD016133-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and Mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"S1157","DOI":"10.1016\/j.ajog.2020.09.014","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","volume":"226","author":"Tong","year":"2022","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD016133-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12916-022-02582-z","article-title":"Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles","volume":"20","author":"McDougall","year":"2022","journal-title":"BMC Medicine"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD016133-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"e2135371","DOI":"10.1001\/jamanetworkopen.2021.35371","article-title":"Trends in use and expenditures for brand-name statins after introduction of generic statins in the US, 2002-2018","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1002\/14651858.CD016133-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/AOG.0000000000003581","article-title":"Maternal and infant health care costs related to preeclampsia","volume":"134","author":"Hao","year":"2019","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD016133-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/jpm-2022-0437","article-title":"Pre-eclampsia and maternal health through the prism of low-income countries","volume":"51","author":"Medjedovic","year":"2022","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD016133-BIB0054|cit54","unstructured":"Preeclampsia Foundation Preeclampsia and maternal mortality: a global burden https:\/\/www.preeclampsia.org\/the-news\/legislative-advocacy\/preeclampsia-and-maternal-mortality-a-global-burden"},{"issue":"71","key":"10.1002\/14651858.CD016133-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016133-BIB0056|cit56","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0057|cit57","unstructured":"National Institute for Health and Care Excellence Hypertension in adults: diagnosis and management https:\/\/www.nice.org.uk\/guidance\/ng136"},{"issue":"2","key":"10.1002\/14651858.CD016133-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ogc.2021.02.002","article-title":"Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology","volume":"48","author":"Damhuis","year":"2021","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"12","key":"10.1002\/14651858.CD016133-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/1471-0528.16319","article-title":"A core outcome set for pre-eclampsia research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"BJOG: An International Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD016133-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajem.2022.06.004","article-title":"High risk and low prevalence diseases: eclampsia","volume":"58","author":"Boushra","year":"2022","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD016133-BIB0061|cit61","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0062|cit62","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD016133-BIB0063|cit63","unstructured":"Alfirevic Z Kellie FJ Weeks J Stewart F Jones L Hampson L on behalf of the Pregnancy and Childbirth Editorial Board Identifying and handling potentially untrustworthy trials\u2014Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group https:\/\/documentation.cochrane.org\/download\/attachments\/169771061\/PGC%20TST%20FINAL.pdf?version=1&modificationDate=1694523757481&api=v2"},{"issue":"8","key":"10.1002\/14651858.CD016133-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD016133-BIB0065|cit65","unstructured":"Li T Higgins JPT Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0066|cit66","unstructured":"Microsoft Excel Microsoft Corporation 2024"},{"key":"10.1002\/14651858.CD016133-BIB0067|cit67","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0068|cit68","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0069|cit69","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016133-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e076754","DOI":"10.1136\/bmj-2023-076754","article-title":"ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis","volume":"383","author":"Page","year":"2023","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD016133-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016133-BIB0073|cit73","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD016133-BIB0074|cit74","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016133-BIB0076|cit76","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0077|cit77","unstructured":"Hamadeh N Van Rompaey C Metreau E World Bank Group country classifications by income level for FY24 (July 1, 2023 \u2013 June 30, 2024) www.blogs.worldbank.org\/en\/opendata\/new-world-bank-group-country-classifications-income-level-fy24"},{"key":"10.1002\/14651858.CD016133-BIB0078|cit78","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD016133-BIB0079|cit79","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD016133-BIB0080|cit80","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD016133-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD016133-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"e049981","DOI":"10.1136\/bmjopen-2021-049981","article-title":"Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review","volume":"11","author":"Karumbi","year":"2021","journal-title":"BMJ Open"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:52:31Z","timestamp":1742298751000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016133"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016133","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]}}}